724 related articles for article (PubMed ID: 21627751)
21. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
Cooper DE; L'esperance JO; Christman MS; Auge BK
J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
[TBL] [Abstract][Full Text] [Related]
22. [Treatment and prognosis of testicular seminoma].
Tsukamoto T; Fukui I
Gan To Kagaku Ryoho; 2000 Apr; 27(4):516-21. PubMed ID: 10790992
[TBL] [Abstract][Full Text] [Related]
23. Stage I seminoma: what should a practicing uro-oncologist do in 2009?
Skliarenko J; Vesprini D; Warde P
Int J Urol; 2009 Jun; 16(6):544-51. PubMed ID: 19453548
[TBL] [Abstract][Full Text] [Related]
24. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
[TBL] [Abstract][Full Text] [Related]
25. Management of stage I testicular seminoma over a period of 49 years.
Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
[TBL] [Abstract][Full Text] [Related]
26. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
27. Management of stage I testis cancer.
Albers P
Eur Urol; 2007 Jan; 51(1):34-43; discussion 43-4. PubMed ID: 16996677
[TBL] [Abstract][Full Text] [Related]
28. [A clinical study of testicular tumors].
Matsuki H; Ozono S; Arai K; Saka M; Cho M; Nakagawa Y; Kaneko Y; Yoshida K; Okamoto S; Maruyama Y
Hinyokika Kiyo; 1988 Oct; 34(10):1757-65. PubMed ID: 2854363
[TBL] [Abstract][Full Text] [Related]
29. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Pedraza AM; Stephenson AJ
Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
[TBL] [Abstract][Full Text] [Related]
30. Exploration of treatment options for the management of stage I testicular seminoma.
Bernal F; Raman JD
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1081-90. PubMed ID: 18588453
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
32. Stage I testicular seminoma: management and controversies.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 Jul; 71(1):22-8. PubMed ID: 19046898
[TBL] [Abstract][Full Text] [Related]
33. Management of stage I testicular germ cell tumours.
Chovanec M; Hanna N; Cary KC; Einhorn L; Albany C
Nat Rev Urol; 2016 Nov; 13(11):663-673. PubMed ID: 27618772
[TBL] [Abstract][Full Text] [Related]
34. The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996.
Steele GS; Richie JP; Stewart AK; Menck HR
Cancer; 1999 Nov; 86(10):2171-83. PubMed ID: 10570449
[TBL] [Abstract][Full Text] [Related]
35. Long term outcome and cost in the management of stage I testicular seminoma.
Warde P; Gospodarowicz MK; Panzarella T; Chow E; Murphy T; Catton CN; Sturgeon JF; Moore M; Milosevic M; Jewett MA
Can J Urol; 2000 Apr; 7(2):967-72; discussion 973.. PubMed ID: 11119439
[TBL] [Abstract][Full Text] [Related]
36. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
37. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
38. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
39. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.
Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
[TBL] [Abstract][Full Text] [Related]
40. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]